loadpatents
Patent applications and USPTO patent grants for Moore; Laurence.The latest application filed is for "antineoplastic combinations with mtor inhibitor, trastuzumab and/or hki-272".
Patent | Date |
---|---|
Antineoplastic combinations with mTOR inhibitor, trastuzumab and/or HKI-272 Grant 10,729,672 - Moore , et al. | 2020-08-04 |
Antineoplastic Combinations with mTOR Inhibitor, Trastuzumab and/or HKI-272 App 20140050721 - Moore; Laurence ;   et al. | 2014-02-20 |
Antineoplastic Combinations with mTOR Inhibitor, Trastuzumab and/or HKI-272 App 20120308560 - Moore; Laurence ;   et al. | 2012-12-06 |
ANTINEOPLASTIC COMBINATIONS WITH mTOR INHIBITOR, TRASTUZUMAB, AND/OR HKI-272 App 20090297519 - Moore; Laurence ;   et al. | 2009-12-03 |
Antineoplastic combinations of temsirolimus and sunitinib malate App 20070105887 - Moore; Laurence | 2007-05-10 |
Antineoplastic combinations with mTOR inhibitor,herceptin, and/or hki-272 App 20070104721 - Moore; Laurence ;   et al. | 2007-05-10 |
Antineoplastic combinations of CCI-779 and rituximab App 20050272758 - Bayever, Eliel ;   et al. | 2005-12-08 |
NCAGE Code | 6UR94 | MOORE, LAURENCE |
CAGE Code | 6UR94 | MOORE, LAURENCE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.